The aforementioned stocks came out with the best returns in the calendar year 2013. Barring Ajanta Pharmaceuticals, all other stocks are either overpriced or having not so good fundamentals.
Ajanta Pharma's fair price is around Rs. 730 and at price levels above this, accumulation can be done in small quantities.
Though Vaibhav Global saw its Q2 net-profit increasing six times but this stock is too over-priced.
Ajanta Pharma's fair price is around Rs. 730 and at price levels above this, accumulation can be done in small quantities.
Though Vaibhav Global saw its Q2 net-profit increasing six times but this stock is too over-priced.
Comments
Post a Comment